In vivo 1H-NMR microimaging with respiratory triggering for monitoring adoptive immunotherapy of metastatic mouse lymphoma

Magn Reson Med. 1997 Sep;38(3):440-55. doi: 10.1002/mrm.1910380313.

Abstract

The metastatic ESb-MP murine lymphoma in DBA/2 mice has been used as a model for investigating metastatic disease and its cure by adoptive immunotherapy (ADI) as monitored by in vivo multislice spin-echo 1H NMR microimaging at 7 T. isoflurane inhalation anesthesia facilitated long measurement sessions, and respiratory gating with a fiber-optic sensor greatly reduced motional artifacts. With T2 weighting (TR = 2 s, TE = 30 ms) mean signal-to-noise ratios of 30 and 15 for kidney and liver, respectively, were achieved in 20 min (100-micron pixels, 1-mm slices, 25-mm field of view). Without the use of contrast agents, metastases with diameters > or = 0.3 mm in the imaged plane could be detected as hyperintense lesions in kidney (contrast ratio ca. 1.4) and liver (contrast ratio ca. 2) with a confidence level of > 98%. For the first time the complete eradication of late-stage macroscopic metastases by ADI could be demonstrated noninvasively by MRI.

MeSH terms

  • Animals
  • Artifacts
  • Disease Models, Animal
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Immunotherapy, Adoptive*
  • Kidney Neoplasms / physiopathology
  • Kidney Neoplasms / secondary*
  • Kidney Neoplasms / therapy
  • Liver Neoplasms / physiopathology
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / therapy
  • Lung Neoplasms / physiopathology
  • Lung Neoplasms / secondary*
  • Lung Neoplasms / therapy
  • Lymphoma / diagnosis*
  • Lymphoma / physiopathology
  • Lymphoma / therapy
  • Magnetic Resonance Spectroscopy / methods*
  • Mice
  • Mice, Inbred DBA
  • Respiration / physiology*
  • Treatment Outcome